Results 221 to 230 of about 9,858,231 (365)

EXCESS OF SALT IN THE DIET A PROBABLE FACTOR IN THE CAUSATION OF CANCER.1 [PDF]

, 1901
James Braithwaite
openalex   +1 more source

Polyfunctional CD8+CD226+RUNX2hi effector T cells are diminished in advanced stages of chronic lymphocytic leukemia

Molecular Oncology, EarlyView.
CD226+CD8+ T cells express elevated levels of RUNX2, exhibit higher proliferation capacity, cytokines and cytolytic molecules expression, and migratory capacity. In contrast, CD226−CD8+ T cells display an exhausted phenotype associated with the increased expression of co‐inhibitory receptors and impaired effector functions.
Maryam Rezaeifar, Shima Shahbaz, Anthea C. Peters, Spencer B. Gibson, Shokrollah Elahi   +4 more
wiley   +1 more source

Therapeutic Assays of the New York Skin and Cancer Unit, Post Graduate Medical School, New York University-Bellevue Medical Center

, 1949
Frances Pascher, Mabel G. Silverberg, Irving E. Marks, Joseph Markel   +3 more
openalex   +1 more source

The HUNTERIAN LECTURE on WHAT OPERATION CAN DO for CANCER of the TONGUE: Delivered before the Hunterian Society, February 23rd, 1898 [PDF]

, 1898
H. T. Butlin
openalex   +1 more source

Inhibition of acyl‐CoA synthetase long‐chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction

Molecular Oncology, EarlyView.
Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy, Heather Fairfield, Victoria E. DeMambro, Samaa Fadel, Carlos A. Gartner, Michelle Karam, Christian Potts, Princess Rodriguez, Ya‐Wei Qiang, Habib Hamidi, Xiangnan Guan, Calvin P. H. Vary, Michaela R. Reagan   +12 more
wiley   +1 more source

Illness risk representations underlying women's breast cancer risk appraisals: A theory-informed qualitative analysis. [PDF]

Br J Health Psychol
Woof VG, McWilliams L, Evans DG, Howell A, French DP.   +4 more
europepmc   +1 more source

Uterine Cancer Morbidity Data: Memphis and Shelby County, Tenn., 1950-51 [PDF]

, 1954
John E. Dunn, John Rowan, Cyrus C. Erickson, Edward E. Siegler   +3 more
openalex   +1 more source

TRPM4 contributes to cell death in prostate cancer tumor spheroids, and to extravasation and metastasis in a zebrafish xenograft model system

Molecular Oncology, EarlyView.
Transient receptor potential melastatin‐4 (TRPM4) is overexpressed in prostate cancer (PCa). Knockout of TRPM4 resulted in reduced PCa tumor spheroid size and decreased PCa tumor spheroid outgrowth. In addition, lack of TRPM4 increased cell death in PCa tumor spheroids.
Florian Bochen, Saurav Subedi, Federico La Manna, Sofia Jarrin, Irida Papapostolou, Marianna Kruithof‐de Julio, Christine Peinelt   +6 more
wiley   +1 more source

Correction: Preferences of patients with high-risk HR+/HER2- breast cancer for adjuvant endocrine treatment: an adaptive choice-based conjoint analysis study from Germany. [PDF]

Breast Cancer Res Treat
Wöckel A, Park-Simon TW, Korfel A, Raab K, Tesch H.   +4 more
europepmc   +1 more source

THE SOCIAL FACTOR IN THE GENESIS OF CANCER. [PDF]

, 1900
C.N. Saldanha
openalex   +1 more source